ID GGACT_HUMAN Reviewed; 153 AA. AC Q9BVM4; B3KTN1; Q9BT41; DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2004, sequence version 2. DT 04-NOV-2026, entry version 163. DE RecName: Full=Gamma-glutamylaminecyclotransferase; DE Short=GGACT; DE EC=4.3.2.8 {ECO:0000269|PubMed:20110353}; DE AltName: Full=AIG2-like domain-containing protein 1; DE AltName: Full=Gamma-glutamylamine cyclotransferase; GN Name=GGACT; Synonyms=A2LD1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057823; DOI=10.1038/nature02379; RA Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., RA Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., RA Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., RA Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L., RA Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., RA Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., RA Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., RA Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., RA Frankish A.G., Frankland J., French L., Garner P., Garnett J., RA Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., RA Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., RA Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., RA Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., RA Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., RA Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., RA Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., RA Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., RA Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., RA Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., RA Rogers J., Ross M.T.; RT "The DNA sequence and analysis of human chromosome 13."; RL Nature 428:522-528(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP X-RAY CRYSTALLOGRAPHY IN COMPLEX WITH 5-OXOPROLINE AND NITRATE, FUNCTION, RP CATALYTIC ACTIVITY, SUBUNIT, ACTIVE SITE, AND MUTAGENESIS OF GLU-82. RX PubMed=20110353; DOI=10.1074/jbc.m109.082099; RA Oakley A.J., Coggan M., Board P.G.; RT "Identification and characterization of gamma-glutamylamine RT cyclotransferase, an enzyme responsible for gamma-glutamyl-epsilon-lysine RT catabolism."; RL J. Biol. Chem. 285:9642-9648(2010). CC -!- FUNCTION: Contributes to degradation of proteins cross-linked by CC transglutaminases by degrading the cross-link between a lysine and a CC glutamic acid residue. Catalyzes the formation of 5-oxo-L-proline from CC L-gamma-glutamyl-L-epsilon-lysine. Inactive with L-gamma-glutamyl- CC alpha-amino acid substrates such as L-gamma-glutamyl-L-alpha-cysteine CC and L-gamma-glutamyl-L-alpha-alanine. {ECO:0000269|PubMed:20110353}. CC -!- CATALYTIC ACTIVITY: CC Reaction=epsilon-(gamma-L-glutamyl)-L-lysine = 5-oxo-L-proline + L- CC lysine; Xref=Rhea:RHEA:16961, ChEBI:CHEBI:32551, ChEBI:CHEBI:58402, CC ChEBI:CHEBI:133752; EC=4.3.2.8; CC Evidence={ECO:0000269|PubMed:20110353}; CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20110353}. CC -!- INTERACTION: CC Q9BVM4; O43679: LDB2; NbExp=3; IntAct=EBI-10299852, EBI-2865580; CC Q9BVM4; Q96KN8-3: PLAAT5; NbExp=8; IntAct=EBI-10299852, EBI-10290304; CC Q9BVM4; O96006: ZBED1; NbExp=3; IntAct=EBI-10299852, EBI-740037; CC -!- SIMILARITY: Belongs to the gamma-glutamylcyclotransferase family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH04360.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK095850; BAG53143.1; -; mRNA. DR EMBL; AL136526; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471085; EAX09037.1; -; Genomic_DNA. DR EMBL; BC001077; AAH01077.2; -; mRNA. DR EMBL; BC004360; AAH04360.1; ALT_INIT; mRNA. DR CCDS; CCDS45066.1; -. DR RefSeq; NP_001182016.1; NM_001195087.2. DR RefSeq; NP_149101.1; NM_033110.3. DR RefSeq; XP_011519431.1; XM_011521129.4. DR RefSeq; XP_047286664.1; XM_047430708.1. DR RefSeq; XP_054231054.1; XM_054375079.1. DR RefSeq; XP_054231055.1; XM_054375080.1. DR PDB; 3JUB; X-ray; 1.20 A; A=1-153. DR PDB; 3JUC; X-ray; 1.20 A; A=1-153. DR PDB; 3JUD; X-ray; 0.98 A; A=1-153. DR AlphaFoldDB; Q9BVM4; -. DR SMR; Q9BVM4; -. DR BioGRID; 124581; 10. DR FunCoup; Q9BVM4; 148. DR IntAct; Q9BVM4; 10. DR STRING; 9606.ENSP00000365426; -. DR DrugBank; DB01942; Formic acid. DR GlyGen; Q9BVM4; 1 site. DR BioMuta; GGACT; -. DR DMDM; 74752384; -. DR jPOST; Q9BVM4; -. DR MassIVE; Q9BVM4; -. DR PaxDb; 9606-ENSP00000365426; -. DR PeptideAtlas; Q9BVM4; -. DR ProteomicsDB; 79220; -. DR Pumba; Q9BVM4; -. DR Antibodypedia; 57333; 89 antibodies from 17 providers. DR DNASU; 87769; -. DR Ensembl; ENST00000376250.6; ENSP00000365426.1; ENSG00000134864.12. DR Ensembl; ENST00000455100.2; ENSP00000410449.1; ENSG00000134864.12. DR Ensembl; ENST00000683975.1; ENSP00000508020.1; ENSG00000134864.12. DR Ensembl; ENST00000881872.1; ENSP00000551931.1; ENSG00000134864.12. DR Ensembl; ENST00000881873.1; ENSP00000551932.1; ENSG00000134864.12. DR Ensembl; ENST00000881874.1; ENSP00000551933.1; ENSG00000134864.12. DR GeneID; 87769; -. DR KEGG; hsa:87769; -. DR MANE-Select; ENST00000683975.1; ENSP00000508020.1; NM_001195087.2; NP_001182016.1. DR UCSC; uc001voq.2; human. DR AGR; HGNC:25100; -. DR ClinPGx; PA164714645; -. DR CTD; 87769; -. DR DisGeNET; 87769; -. DR GeneCards; GGACT; -. DR HGNC; HGNC:25100; GGACT. DR HPA; ENSG00000134864; Tissue enriched (kidney). DR MIM; 613378; gene. DR OpenTargets; ENSG00000134864; -. DR VEuPathDB; HostDB:ENSG00000134864; -. DR eggNOG; KOG4450; Eukaryota. DR GeneTree; ENSGT00390000010543; -. DR HOGENOM; CLU_083466_1_0_1; -. DR InParanoid; Q9BVM4; -. DR OMA; AAMTHWV; -. DR OrthoDB; 113620at2759; -. DR PAN-GO; Q9BVM4; 1 GO annotation based on evolutionary models. DR PhylomeDB; Q9BVM4; -. DR BRENDA; 4.3.2.8; 2681. DR BRENDA; 4.3.2.9; 2681. DR PathwayCommons; Q9BVM4; -. DR SignaLink; Q9BVM4; -. DR Agora; ENSG00000134864; -. DR BioGRID-ORCS; 87769; 9 hits in 1144 CRISPR screens. DR ChiTaRS; GGACT; human. DR EvolutionaryTrace; Q9BVM4; -. DR GenomeRNAi; 87769; -. DR Pharos; Q9BVM4; Tbio. DR PRO; PR:Q9BVM4; -. DR Proteomes; UP000005640; Chromosome 13. DR RNAct; Q9BVM4; protein. DR Bgee; ENSG00000134864; Expressed in secondary oocyte and 110 other cell types or tissues. DR ExpressionAtlas; Q9BVM4; baseline and differential. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0061929; F:gamma-glutamylaminecyclotransferase activity; IDA:UniProtKB. DR GO; GO:0042219; P:modified amino acid catabolic process; IDA:UniProtKB. DR CDD; cd06661; GGCT_like; 1. DR FunFam; 3.10.490.10:FF:000008; Gamma-glutamylaminecyclotransferase A; 1. DR Gene3D; 3.10.490.10; Gamma-glutamyl cyclotransferase-like; 1. DR InterPro; IPR009288; AIG2-like_dom. DR InterPro; IPR039126; GGACT. DR InterPro; IPR013024; GGCT-like. DR InterPro; IPR036568; GGCT-like_sf. DR PANTHER; PTHR12510:SF4; GAMMA-GLUTAMYLAMINECYCLOTRANSFERASE; 1. DR PANTHER; PTHR12510; TROPONIN C-AKIN-1 PROTEIN; 1. DR Pfam; PF06094; GGACT; 1. DR SUPFAM; SSF110857; Gamma-glutamyl cyclotransferase-like; 1. PE 1: Evidence at protein level; KW 3D-structure; Lyase; Proteomics identification; Reference proteome. FT CHAIN 1..153 FT /note="Gamma-glutamylaminecyclotransferase" FT /id="PRO_0000320203" FT REGION 130..153 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 132..153 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 82 FT /note="Proton acceptor" FT /evidence="ECO:0000269|PubMed:20110353" FT BINDING 7..10 FT /ligand="substrate" FT MUTAGEN 82 FT /note="E->A,Q: Loss of activity." FT /evidence="ECO:0000269|PubMed:20110353" FT STRAND 2..6 FT /evidence="ECO:0007829|PDB:3JUD" FT HELIX 17..20 FT /evidence="ECO:0007829|PDB:3JUD" FT HELIX 23..25 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 28..38 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 42..45 FT /evidence="ECO:0007829|PDB:3JUD" FT TURN 46..49 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 50..55 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 59..61 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 64..70 FT /evidence="ECO:0007829|PDB:3JUD" FT HELIX 72..81 FT /evidence="ECO:0007829|PDB:3JUD" FT TURN 82..86 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 89..98 FT /evidence="ECO:0007829|PDB:3JUD" FT STRAND 113..121 FT /evidence="ECO:0007829|PDB:3JUD" FT HELIX 126..130 FT /evidence="ECO:0007829|PDB:3JUD" SQ SEQUENCE 153 AA; 17329 MW; 1A01F350F761D208 CRC64; MALVFVYGTL KRGQPNHRVL RDGAHGSAAF RARGRTLEPY PLVIAGEHNI PWLLHLPGSG RLVEGEVYAV DERMLRFLDD FESCPALYQR TVLRVQLLED RAPGAEEPPA PTAVQCFVYS RATFPPEWAQ LPHHDSYDSE GPHGLRYNPR ENR //